B+
Bull case
20%
Probability
Target price
$8.50
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
AHCO
AdaptHealthBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
55%
Probability
Target price
$6.20
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$4.20
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-07
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+68.6
Score
AI commentary
Primary evidence is strong but directionally mixed. Q2 showed robust organic growth and strategic simplification, while the sharp guidance reduction, weaker EBITDA, negative year-to-date free cash flow, and goodwill write-down dominate the risk assessment. The current anchor is $6.045 as of 2026-08-06; a clean post-print price-reaction series and analyst revision set are unavailable, so this remains a cautious monitoring view.
RankAlpha Sentiment Codex - 2026-08-07
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-11-05eventDiabetes divestiture and debt actions may simplify the portfolioHigh impact
AdaptHealth agreed to sell Diabetes Health for $235 million in cash, redeemed its 6.125% senior notes, and is concentrating on Sleep, Respiratory, and Wellness at Home. Execution and closing proceeds remain the key tests. [#SEC-8K-2026-08-04]
2026-11-05catalystGuidance reset creates an immediate margin-repair testHigh impact
Q2 delivered 15.9% organic growth and 12.7% reported revenue growth, but Adjusted EBITDA fell 3.2% and management lowered FY2026 guidance because of capitated-contract transition costs, a manufacturer price increase, and portfolio actions. [#SEC-8K-2026-08-04]
2027-08-07catalystCapitated scale, digital engagement, and cost actions could improve core economicsHigh impact
The West Coast capitated partnership reached full scale, Humana OneHome coverage transitioned approximately 478,000 members, myAPP users exceeded 512,000, and restructuring is expected to generate $19 million in annualized savings. The upside depends on converting scale into improved margins and cash flow. [#SEC-8K-2026-08-04]
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-07 • Updated nightlySource: Internal modelMethodology